Erlotinib and Ramucirumab
About
Membership operator: AND
Therapies: 2
Therapies
Erlotinib (tx:ncit:C65530)
Ramucirumab (tx:ncit:C70792)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | EGFR Exon 19 (Deletion) | Non-Small Cell Lung Cancer | Erlotinib, Ramucirumab | |
| FDA (2) | EGFR p.L858R | Non-Small Cell Lung Cancer | Erlotinib, Ramucirumab | |
| EMA (1) | EGFR activating variants | Non-Small Cell Lung Cancer | Erlotinib, Ramucirumab |